| Literature DB >> 25471829 |
Lone Flarup1, Anders Helles Carlsen, Grete Moth, Morten Bondo Christensen, Mogens Vestergaard, Frede Olesen, Peter Vedsted.
Abstract
OBJECTIVE: Little is known about the prognosis of patients with chronic disease who contact the out-of-hours (OOH) service in primary care. The characteristics of contacts with the Danish out-of-hours service and daytime general practice, hospitalization, and death were studied during a 30-day follow-up period in patients with chronic heart diseases.Entities:
Keywords: Chronic disease; Denmark; OOH; general practice; out-of-hours service; primary healthcare; reasons for encounter
Mesh:
Year: 2014 PMID: 25471829 PMCID: PMC4278395 DOI: 10.3109/02813432.2014.984964
Source DB: PubMed Journal: Scand J Prim Health Care ISSN: 0281-3432 Impact factor: 2.581
Figure 1.Sources and codes for identification of patients with five chronic diseases.
Figure 2.Remuneration codes for services provided by general practice (used in this study).
Proportions of patients who either had a new contact with the OOH, a contact with the daytime GP, a hospital admission, or died during a 30-day follow-up after OOH contact: Distribution shows the five chronic diseases, the 2 + diagnosed, and other patients.1,2
| Heart disease | Lung disease | Diabetes | Psychiatric disease | Cancer | 2 + diagnosed | Other patients | Total population | |||||||||
| Exacerbation | ||||||||||||||||
| Proportion, n (%): | ||||||||||||||||
| OOH | 27 | (19.1) | 96 | (19.1) | 63 | (15.2) | 31 | (24.6) | 64 | (20.5) | 75 | (24.1) | 132 | (13.2) | 335 | (15.7) |
| Daytime GP | 109 | (74.9) | 414 | (70.6) | 277 | (71.2) | 76 | (59.1) | 235 | (68.8) | 262 | (69.5) | 639 | (64.9) | 1438 | (67.1) |
| Hospital admission | 43 | (34.5) | 139 | (25.4) | 93 | (24.0) | 45 | (30.0) | 72 | (27.2) | 90 | (3.8) | 243 | (21.7) | 520 | (23.1) |
| Death | 15 | (8.7) | 37 | (10.0) | 2 | (0.5) | 47 | (16.4) | 36 | (14.1) | 24 | (1.5) | 108 | (1.5) | 108 | (4.6) |
| New health problem | ||||||||||||||||
| Proportion, n (%): | ||||||||||||||||
| OOH | 41 | (15.6) | 137 | (14.2) | 139 | (12.0 | 43 | (24.7) | 111 | (8.7) | 85 | (21.6) | 676 | (12.8) | 1043 | (10.8) |
| Daytime GP | 248 | (67.8) | 749 | (67.3) | 851 | (72.9) | 148 | (62.9) | 813 | (69.4) | 561 | (73.5) | 3,938 | (56.2) | 6094 | (59.5) |
| Hospital admission | 87 | (32.0) | 260 | (24.1) | 305 | (27.8) | 61 | (25.7) | 72 | (26.4) | 192 | (1.6) | 1,446 | (18.5) | 2229 | (20.4) |
| Death | 29 | (9.9) | 50 | (3.49) | 62 | (4.3) | 2 | (0.2) | 85 | (6.9) | 61 | (7.3) | 81 | (0.5) | 234 | (1.4) |
Notes: 1Contact distribution-related weighted estimates (95% confidence interval). 2Patients with more than one of the five chronic diseases were included in the numerator for each specific disease; hence the sum of all diseases sum to more than the total population.
Risk for patients with an OOH index contact due to an exacerbation for new contact with OOH, contact with daytime GP, hospital admission, or death during 30-day follow-up, distributed over the five chronic diseases, for other patients, and for the total population (shown as incidence risk rate [IRR]).
| Heart disease | Lung disease | Diabetes | Psychiatric disease | Cancer | 2 + diagnosed | Other patients | Total population | |||||||||
| IRRs of outcome for patients with exacerbation:1 | ||||||||||||||||
| IRR (95%CI) | ||||||||||||||||
| OOH | 2.90 | (2.02;4.17) | 1.72 | (1.38;2.15) | 2.23 | (1.74;2.87) | 2.00 | (1.32;3.03) | 2.40 | (1.90;3.04) | 2.11 | (1.68;2.71) | 2.25 | (1.91;2.64) | 2.50 | (2.24;2.79 |
| Daytime GP | 1.43 | (1.22;1.66) | 1.28 | (1.12;1.40) | 1.39 | (1.26;1.54) | 1.29 | (1.02;1.64) | 1.43 | (1.28;1.60) | 1.31 | (1.18;1.46) | 1.56 | (1.45;1.67) | 1.57 | (1.50;1.65) |
| Hospital admission | 1.11 | (0.90;1.36) | 0.99 | (0.93;1.06) | 1.00 | (0.92;1.09) | 0.98 | (0.94;1.01) | 1.04 | (0.94;1.17) | 0.95 | (0.85;1.06) | 0.99 | (0.97;1.00) | 1.01 | (0.99;1.04) |
| Death | 0.99 | (0.94;1.04) | 1.29 | (1.19;1.40) | 1.21 | (1.00;1.31) | 1.01 | (0.99;1.05) | 1.43 | (1.29;1.59) | 1.26 | (1.15;1.36) | 0.92 | (0.85;0.98) | 1.07 | (0.86;1.34) |
Note: 1 Patients who presented as “new health problem” as reference.
Odds ratios (OR) for OOH users within each of the five disease groups for getting in contact with the healthcare system or dying during the 30-day follow-up (patients without chronic disease served as reference group).1,2
| Odds ratio (95% CI) | |||||||||||||||||||||||||||||||
| OOH | Daytime GP | Hospital admission | Death | ||||||||||||||||||||||||||||
| Crude | Adjusted3 | Crude | Adjusted3 | Crude | Adjusted3 | Crude | Adjusted3 | ||||||||||||||||||||||||
| Heart disease | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.17 | (0.04;0.69) | 0.32 | (0.08;1.30) | 0.90 | (0.53;1.51) | 0.67 | (0.39;1.18) | 2.27 | (1.25;4.11) | 1.64 | (0.90;3.01) | 14.98 | (5.62;39.95) | 4.71 | (1.80;12.30) | |||||||||||||||
| New health problem | 1.16 | (0.45;2.96) | 2.30 | (0.90;5.93) | 1.03 | (0.73;1.44) | 0.82 | (0.57;1.18) | 2.03 | (1.35;3.04) | 1.41 | (0.92;2.14) | 17.17 | (8.37;35.25) | 3.00 | (1.39;6.51) | |||||||||||||||
| Lung disease: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.46 | (0.25;0.83) | 0.75 | (0.40;1.38) | 0.98 | (0.75;1.29) | 0.76 | (0.57;1.02) | 1.46 | (1.07;2.01) | 1.13 | (0.82;1.59) | 14.93 | (7.76;28.72) | 5.42 | (2.82;10.40) | |||||||||||||||
| New health problem | 0.94 | (0.56;1.59) | 1.27 | (0.90;1.80) | 1.08 | (0.9;1.30 | 0.93 | (0.78;1.14) | 1.36 | (1.09;1.70) | 1.18 | (0.94;1.48) | 5.57 | (3.06;5.80) | 2.03 | (1.43;2.88) | |||||||||||||||
| Diabetes: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.63 | (0.19;2.09) | 1.27 | (0.37;4.36) | 0.95 | (0.69;1.31) | 0.77 | (0.55;1.09) | 1.36 | (0.90;2.03) | 1.01 | (0.67;1.52) | 17.49 | (8.76;34.93) | 5.83 | (2.74;12.39) | |||||||||||||||
| New health problem | 0.95 | (0.55;1.65) | 1.63 | (0.90;2.95) | 1.47 | (1.21;1.76) | 1.25 | (1.03;1.52) | 1.66 | (1.34;2.05) | 1.32 | (1.05;1.65) | 6.96 | (4.09;11.85) | 2.82 | (1.53;5.14) | |||||||||||||||
| Psychiatric disease: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.25 | (0.09;0.70) | 0.34 | (0.12;0.96) | 0.34 | (0.19;0.61) | 0.31 | (0.17;0.57) | 1.84 | (1.03;3.29) | 1.64 | (0.91;2.94) | 0.77 | (0. 18;3.28) | 1.62 | (0.33;7.87) | |||||||||||||||
| New health problem | 2.23 | (1.08;4.63) | 2.45 | (1.18;5.08) | 0.76 | (0.53;1.08) | 0.78 | (0.51;1.05) | 1.49 | (0.98;2.26) | 1.46 | (0.95;2.25) | 0.33 | (0.0.8;1.40) | 0.81 | (0.16;4.01) | |||||||||||||||
| Cancer: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.63 | (0.21;1.85) | 1.03 | (0.35;3.08) | 0.86 | (0.61;1.22) | 0.67 | (0.47;0.96) | 1.60 | (1.02;2.49) | 1.24 | (0.99;1.93) | 30.76 | (16.43;57.61) | 12.65 | (6.19;25.87) | |||||||||||||||
| New health problem | 0.58 | (0.31;1.11) | 0.90 | (0.48;1.70) | 1.35 | (1.12;1.62) | 1.06 | (0.87;1.28) | 1.54 | (1.23;1.93) | 1.23 | (0.98;1.56) | 11.67 | (7.10;19.17) | 4.06 | (2.40;6.90) | |||||||||||||||
| 2 + diagnosed: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.34 | (0.15;0.79) | 0.67 | (0.29;1.58) | 0.65 | (0.46;0.92) | 0.47 | (0.33;0.69) | 2.39 | (1.59;3.59) | 1.71 | (1.12;2.61) | 25.68 | (12.97;50.86) | 8.97 | (4.55;17.68) | |||||||||||||||
| New health problem | 0.53 | (0.22;1.27) | 0.91 | (0.39;2.12) | 1.26 | (1.00;1.59) | 0.99 | (0.77;1.26) | 1.00 | (0.90;1.10) | 1.00 | (0.92;1.11) | 12.33 | (7.06;21.53) | 3.96 | (2.18;7.19) | |||||||||||||||
Notes: 1Patients without any of the five chronic diseases served as reference group. 2Contact distribution-related weighted estimates (95% confidence interval). 3Adjusted for gender and age.
Distribution of patients who died during the 30-day follow-up period after OOH contact with respect to age, exacerbation, or new health problem, and gender.1
| Heart | Lung | Diabetes | Psychiatric | Cancer | 2 + diagosed | |||||||
| All deaths | 44 | (9.6) | 87 | (4.7) | 93 | (5.5) | 4 | (0.3) | 132 | (8.7) | 97 | (9.0) |
| Age groups: | ||||||||||||
| < 60 years | 0 | (0) | 6 | (7.8) | 4 | (5.9) | 1 | (25.0) | 11 | (16.0) | 12 | (13.8) |
| 61–75 years | 10 | (10.2) | 24 | (19.3) | 25 | (15.5) | 3 | (75.0) | 49 | (28.3) | 38 | (21.0) |
| 75 + years | 34 | (89.8) | 57 | (72.9) | 64 | (78.5) | 0 | (0) | 72 | (55.7) | 90 | (65.2) |
| Exacerbation | 15 | (24.5) | 37 | (43.8) | 31 | (38.8) | 2 | (50.0) | 47 | (35.8) | 48 | (36.2) |
| New health problem | 29 | (75.5) | 50 | (56.2) | 62 | (61.2) | 2 | (50.0) | 85 | (64.2) | 92 | (63.8) |
| Gender: | ||||||||||||
| Men | 23 | (69.4) | 41 | (42.2) | 43 | (40.2) | 3 | (75.0) | 62 | (44.3) | 68 | (46.7) |
| Women | 21 | (30.6) | 46 | (57.8) | 50 | (59.8) | 1 | (25.0) | 70 | (55.7) | 72 | (53.3) |
Note: 1In numbers with corresponding contact distribution-related weighted percentage.